GlassScriptPhysician profile
Gaudencio Olgin
NPI 1790049732
$12,102.72
in general payments reported to CMS, 2019-2025
21 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $147 · 2021: $67.65 · 2022: $9,223 · 2023: $215 · 2024: $396 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.23 |
| Education | $256.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,935.37 | 2019-2024 | |
| Medtronic, INC. | $306.92 | 2023-2025 | Interstim, Signia |
| Astellas Pharma US INC | $286.24 | 2019-2025 | |
| Biotissue Holdings INC. | $250.06 | 2025 | |
| Boston Scientific Corporation | $198.21 | 2019-2024 | Lithovue |
| Urogen Pharma, INC. | $166.70 | 2023-2025 | Jelmyto |
| Conmed Corporation | $162.50 | 2025 | Airseal |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $135.55 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $102.40 | 2022 | |
| Davol INC. | $67.65 | 2021 | |
| Coloplast Corp | $66.75 | 2020 | |
| Abbvie INC. | $55.77 | 2024-2025 | |
| Amgen INC. | $51.81 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $43.27 | 2023 | Orgovyx, Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $35.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| 180 Medical, INC. | $17.48 | 2024 | Speedicath |
| Travere Therapeutics, INC. | $16.44 | 2019-2025 | Thiola |
| Axonics, INC. | $15.92 | 2023 | Axonics |
| Janssen Biotech, INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaudencio Olgin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.